UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 ORor 15(d) of ~~The~~the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)~~: December 22, 2014~~

~~Commission~~September ~~File~~1, ~~Number:~~2015 ~~333-189762~~(August 31, 2015)

WEED GROWTH FUND, INC.

formerly Ovation Research, Inc.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction of incorporation ~~or organization~~)

90333-~~0925760~~189762

(~~I.R.S.~~Commission ~~Employer~~File ~~Identification~~ No.)

~~7170~~5635 EN. ~~McDonald~~Scottsdale ~~Rd, Suite 3~~Road

~~Scottsdale,~~Suite ~~AZ 85253~~130

~~(Address~~Scottsdale, ofArizona ~~principal executive offices)~~85250

~~Tel:~~ (~~480)~~Address ~~725-9060~~of principal executive offices and Zip Code

(~~Registrant's telephone number~~480) 725-9060

~~Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the~~ (Registrant's ~~under~~telephone ~~any~~number, ofincluding ~~the~~area ~~following provisions:~~code)

¨Check ~~Written~~the ~~communications~~appropriate ~~pursuant~~box below if the Form 8-K filing is intended to ~~Rule~~simultaneously ~~425~~satisfy the filing obligation of the registrant under any of the ~~Securities~~following ~~Act~~provisions (17see ~~CFR~~General ~~230~~Instruction A.~~425~~2. below):

¨[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~¨ Pre~~-~~commencement communications pursuant to Rule 14d~~-~~2(b) under the Exchange Act (17 CFR 240.14d -2(b))~~

¨ITEM ~~Pre-commencement~~5.02 ~~communications~~DEPARTURE ~~pursuant~~OF toDIRECTORS ~~Rule~~AND ~~13e-4(c)~~CERTAIN ~~under~~OFFICERS; ~~the~~ELECTION ~~Exchange~~OF ~~Act~~DIRECTORS; ~~(17~~APPOINTMENT ~~CFR~~OF ~~240.13e~~CERTAIN ~~-4(c))~~OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

~~ITEM~~On 2August 31, 2015, one shareholder controlling 90% of our common stock removed Eric Miller as our sole officer and director of the Company and replaced him with Ed Rosenthal.01 Mr. –Rosenthal ~~COMPLETION~~is OFa ~~ACQUISITION~~California ORhorticulturist, ~~DISPOSITION~~author, OFpublisher, ~~ASSETS~~businessman and advocate for the legalization of marijuana use. Mr. Rosenthal owns Quick Trading Company, a California publishing company focused on the Cannabis industry and operates the blog edrosenthal.com. He is also the author of numerous books about the cultivation of marijuana and was one of the first to research terpenes in the cannabis plant. Mr. Rosenthal's book entitled "Ed's Growers Handbook" is the official course book for classes at Oaksterdam University. Mr. Rosenthal has previously worked with state and local governments to implement the delivery of pharmaceutical-grade cannabis to patients with a doctor's prescription after approval of California's Proposition 215 authorizing medicinal use of marijuana and was deputized by the City of Oakland for cultivation of marijuana. Mr. Rosenthal is the president of THC Farmaceuticals, Inc. our subsidiary corporation which is traded on the OTC Markets under the symbol CBDG and is designated OTCQB. He is also president of Terpene Research Labs Ltd. a subsidiary corporation of THC Farmaceuticals, Inc.

On December 22, 2014, the Company completed the acquisition of securities under that Contribution Agreement dated September 30, 2014 and issued instructions to issue 5,000,000 shares of the Company’s common stock as a result of that agreement. The Contribution Agreement was previously reported in the Company’s 8-K dated September 30, 2014.SIGNATURES

~~The~~Pursuant ~~securities~~to ~~acquired~~the ~~include~~requirements of the ~~following:~~Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~Hemp,~~Dated ~~Inc.~~this ~~[HEMP]~~1st -day ~~40,000,000 shares~~ of ~~preferred stock~~September, ~~convertible to 100,000~~2015.~~000 shares of common stock.~~

~~Grow~~WEED ~~Condos~~GROWTH FUND, ~~Inc~~INC. ~~(formerly~~BY: ~~Calibrus,~~ED ~~Inc.)~~ROSENTHAL ~~[GRWC]~~Ed ~~- 400~~Rosenthal,~~000~~ ~~shares of common stock~~President

~~Cannabis Sativa [CBDS]~~ - ~~745,000 shares of common stock.~~2-

Medical Marijuana Inc. [MJNA] – an option to purchase 1,000,000 shares of common stock for $0.15 per share until September 24, 2017.

Additional details regarding the acquisition of the foregoing securities is contained in the Company’s 8-K dated September 30, 2014, incorporated herein by reference.

ITEM 3.02 – UNREGISTERED SALE OF EQUITY SECURITIES.

On December 22, 2014, the Company authorized the issuance of 5,000,000 restricted shares of its common stock, par value $0.001 per share, to New Compendium Corporation as a result of the Contribution Agreement described in Item 2.01 and the Company’s 8-K dated September 30, 2014, incorporated herein by reference. The issuance was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, the investors are accredited, sophisticated and familiar with our operations, and there was no solicitation in connection with the issuance.

ITEM 9.01 – FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits:

Exhibit Number		SEC Reference Number				Title of Document				Location
10.1		10				Contribution Agreement dated September 30, 2014				Incorporated by reference to our Form 8-K of the same date, filed on October 21, 2014

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	WEED GROWTH FUND, INC.
Date: December 30, 2014	By:	/s/ Eric Miller
		Eric Miller, President & Director

Filing Compare · Nuclear Diamond Batteries, Inc.